Sign Out
EPILEPSY: Adults and adolescents aged 13 years and above: Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures; Seizures associated with Lennox-Gastaut syndrome. LAMICTAL is given as adjunctive therapy but may be the initial anti-epileptic drug (AED) to start with in Lennox-Gastaut syndrome.
Children and adolescents aged 2 to 12 years: Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome; Monotherapy of typical absence seizures.
BIPOLAR DISORDER: Adults aged 18 years and above: Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes (see Pharmacology: Pharmacodynamics under Actions).
LAMICTAL is not indicated for the acute treatment of manic or depressive episodes.
